Bliss GVS Pharma is currently trading at Rs. 206.50, up by 3.30 points or 1.62% from its previous closing of Rs. 203.20 on the BSE.
The scrip opened at Rs. 211.70 and has touched a high and low of Rs. 211.70 and Rs. 205.00 respectively. So far 129600 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 230.00 on 02-Jan-2018 and a 52 week low of Rs. 129.00 on 07-Jun-2017.
Last one week high and low of the scrip stood at Rs. 216.00 and Rs. 202.85 respectively. The current market cap of the company is Rs. 2125.34 crore.
The promoters holding in the company stood at 60.16%, while institutions and non-institutions held 7.73% and 32.11% respectively.
Bliss GVS Pharma has decided to divest the step down subsidiary of the company, Bliss GVS Healthcare, Nairobi. This decision has been made essentially to lower dependence on Tender Driven Managed Healthcare business and focus on growing the Pharmaceuticals Business. The Board of the Company at their meeting held on January 11, 2018, considered the same.
Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |